SGMO - SANGAMO THERAPEUTICS, INC

QQQ $ 592.61 $ 0.00 (0 %)

DIA $ 455.89 $ 0.00 (0 %)

SPY $ 653.88 $ 0.00 (0 %)

TLT $ 91.49 $ 0.00 (0 %)

GLD $ 399.27 $ 0.00 (0 %)

Previous Close

$ 0.6449

Open

$ 0.69

Bid

$ 0.62 x 49

Ask

$ 0.63 x 43

Day's Range

-- - --

52 Week Range

$ 0.41 - $ 3.18

Volume

4,241,954

Average Volume

Market Cap

194.57M

Beta (5Y Monthly)

$ 1.21

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-17-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-13-2024	12-31-2023	10-K
8	11-01-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	02-23-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	02-24-2021	12-31-2020	10-K
20	11-04-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	02-28-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	03-01-2019	12-31-2018	10-K
28	11-08-2018	09-30-2018	10-Q
29	08-08-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-01-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	02-28-2017	12-31-2016	10-K
36	10-27-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	02-18-2016	12-31-2015	10-K
40	10-30-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

On September 9, Sangamo Therapeutics CFO P...
09/11/2025 21:08:32

-SEC Filing

HC Wainwright & Co. Reiterates Buy on Sang...
09/04/2025 16:12:59

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $...

Sangamo Therapeutics Q2 EPS $(0.08) Misses...
08/07/2025 20:08:37

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

'South Africa, Gates Foundation Pledge Fun...
08/04/2025 16:40:22

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

HC Wainwright & Co. Reiterates Buy on Sang...
06/24/2025 16:40:14

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

Sangamo Therapeutics Announces Topline Res...
06/24/2025 12:10:25

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dose...

Barclays Maintains Overweight on Sangamo T...
05/14/2025 15:07:44

Barclays analyst Gena Wang maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Overweight and lowers the price target from $...

12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 17:06:46

12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

us-stocks-likely-to-open-lower-after-a-strong-rally-lows-are-likely-in-and-better-times-are-coming-says-expert

US Stocks Likely To Open Lower After A Str...
05/13/2025 09:45:38

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in pr...

why-coinbase-global-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket

Why Coinbase Global Shares Are Trading Hig...
05/13/2025 09:28:26

Sangamo Therapeutics Q1 EPS $(0.14) Misses...
05/12/2025 22:38:35

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

Sangamo Therapeutics Prices $23M Underwrit...
05/12/2025 22:25:23

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced the pricing of an underwritten offering c...

12 Health Care Stocks Moving In Monday's A...
05/12/2025 21:06:02

Sangamo Therapeutics Q1 GAAP EPS $(0.14) M...
05/12/2025 20:37:08

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

Sangamo Therapeutics Announces Derisking M...
05/06/2025 12:36:00

All dosed patients have passed one-year milestone required by U.S. Food and Drug Administration (FDA) for Accelerated Approval ...

Sangamo Therapeutics To Present At 28th An...
04/28/2025 20:33:14

HC Wainwright & Co. Reiterates Buy on Sang...
04/07/2025 12:48:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...